Determinants of collateral development in patients with acute myocardial infarction

Related Experiment Videos

M Fujita1, I Nakae, Y Kihara

  • 1College of Medical Technology, Kyoto University, Japan.

Clinical Cardiology
|September 16, 1999
PubMed

Insights

A history of angina pectoris before acute myocardial infarction (AMI) is a significant predictor of well-developed coronary collateral circulation. This finding highlights angina as a clinical marker for collateral vessels, impacting infarct size and heart function.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Clinical Medicine

Background:

  • Coronary collateral circulation significantly influences infarct size and left ventricular function post-acute myocardial infarction (AMI).
  • Determinants of collateral development in AMI patients remain unclear.
  • Understanding collateral circulation is crucial for improving outcomes in myocardial infarction.

Purpose of the Study:

  • To elucidate the determinants of coronary collateral development in humans with AMI.
  • To identify clinical factors predicting the presence of well-developed collateral circulation.

Main Methods:

  • Coronary angiography was performed on 248 patients within 12 hours of a first AMI with complete coronary artery occlusion.
  • Collateral circulation was graded based on contrast opacification of the infarct-related artery.
  • Multivariate logistic regression analyzed predictors including preinfarction angina, coronary artery disease severity, age, gender, and risk factors.

Main Results:

  • 37.1% of patients exhibited well-developed collateral circulation.
  • Patients with a history of angina pectoris prior to AMI had a significantly higher prevalence (57%) of well-developed collaterals compared to those without (26%).
  • A history of angina pectoris was the only significant independent predictor of collateral development (p < 0.0001).

Conclusions:

  • A history of angina pectoris preceding AMI serves as a clinical marker for coronary stenoses.
  • Severe coronary stenoses, indicated by angina, likely stimulate collateral vessel development.
  • Angina history is a valuable clinical marker for assessing coronary collateralization in AMI patients.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...